Egan et al. identified five recently acquired single nucleotide variations (SNVs), including truncating mutations in RB1 and ZKSCAN3, in myeloma patients undergoing leukemic transformation. This evidence concerns the gene ZKSCAN3 and plasma cell myeloma.